Why Former Medivation CEO and a Once-Failed Alzheimer's Drug Could be a Recipe for Disaster for Axovant

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Why Former Medivation CEO and a Once-Failed Alzheimer's Drug Could be a Recipe for Disaster for Axovant" ALT"Why Former Medivation CEO and a Once-Failed Alzheimer's Drug Could be…

Continue ReadingWhy Former Medivation CEO and a Once-Failed Alzheimer's Drug Could be a Recipe for Disaster for Axovant

Johnson & Johnson Hosts 'Shark-Tank'-Like Competition and Crowned This Biotech Startup as Its Winner

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-johnson-johnson.jpg" NAME"Johnson & Johnson Hosts 'Shark-Tank'-Like Competition and Crowned This Biotech Startup as Its Winner" ALT"Johnson & Johnson Hosts 'Shark-Tank'-Like Competition and Crowned This Biotech Startup as Its Winner"April…

Continue ReadingJohnson & Johnson Hosts 'Shark-Tank'-Like Competition and Crowned This Biotech Startup as Its Winner

FDA's Shorten Review Time is a Bad Sign for Puma Biotech's Controversial Cancer Drug

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"FDA's Shorten Review Time is a Bad Sign for Puma Biotech's Controversial Cancer Drug" ALT"FDA's Shorten Review Time is a Bad Sign for Puma Biotech's Controversial Cancer Drug"April…

Continue ReadingFDA's Shorten Review Time is a Bad Sign for Puma Biotech's Controversial Cancer Drug

Novartis AG Remains Hush-Hush About CAR-T Trial But the FDA is Impressed and Thinks It's a Breakthrough

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x400-novartis.jpg" NAME"Novartis AG Remains Hush-Hush About CAR-T Trial But the FDA is Impressed and Thinks It's a Breakthrough" ALT"Novartis AG Remains Hush-Hush About CAR-T Trial But the FDA is…

Continue ReadingNovartis AG Remains Hush-Hush About CAR-T Trial But the FDA is Impressed and Thinks It's a Breakthrough